Inovelon, Suspension zum Einnehmen

7680620660018 CH-62066 suspension

Associated product:

INOVELON susp 40 mg/ml fl 460 ml
Inovelon, Suspension zum Einnehmen
Inovelon, Suspension zum Einnehmen
Inovelon, Suspension zum Einnehmen
1 / 3
google

Article details

Package size
460
Selling units
460
Measure
ml
Galenic form
suspension
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
(N/A)
40.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
175.0 MG Substance HBESI
(N/A)
25.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI
(N/A)
- Substance Konservierungsstoff (Conservateur)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance AROMA
(N/A)
- Substance HBESI
(N/A)
- Substance Konservierungsstoff (Conservateur)
(N/A)
1.2 MG Substance HBESI
(N/A)
0.3 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI

Reimbursement information

Public price
CHF 90.40
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/09/2012

Authorization holder

Eisai Pharma AG

8050 Zürich

Authorization information

Swissmedic authorization number
62066
Drug name
Inovelon, Suspension zum Einnehmen
Galenic form
SUOR
ATC Code
N03AF03
Authorization status
Z
Dispensing category
B
First authorization
13/06/2012
Authorization expiration date
31/12/9999
IT Number
01.07.1.
Domain
Human medicine
Field of application
Zusatztherapie zur Behandlung von Anfällen bei Lennox-Gastaut-Syndrom bei Patienten ab dem 1. Lebensjahr

Package details

Description (FR)
INOVELON susp 40 mg/ml fl 460 ml
Description (DE)
INOVELON Susp 40 mg/ml Fl 460 ml
Market launch
13/06/2012
Narcotic (BTM)
No